Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 7;17(1):19.
doi: 10.1186/s40360-016-0063-z.

Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study

Affiliations

Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study

Charat Thongprayoon et al. BMC Pharmacol Toxicol. .

Abstract

Background: The choice of vasopressor use in the intensive care unit (ICU) depends primarily on provider preference. This study aims to describe the rate of vasopressor utilization and the trends of each vasoactive agent usage in the ICU over the span of 7 years in a tertiary referral center.

Methods: All adult ICU admissions, including medical, cardiac, and surgical ICUs from January 1st, 2007 through December 31st, 2013 were included in this study. Vasopressor use was defined as the continuous intravenous administration of epinephrine, norepinephrine, phenylephrine, dopamine, or vasopressin within a given ICU day. The vasopressor utilization index (VUI) was defined as the proportion of ICU days on each vasoactive agent divided by the total ICU days with vasopressor usage.

Results: During the study period, 72,005 ICU admissions and 272,271 ICU days were screened. Vasopressors were used in 19,575 ICU admissions (27 %) and 59,811 ICU days (22 %). Vasopressin was used in 24,496 (41 %), epinephrine in 23,229 (39 %), norepinephrine in 20,648 (34 %), dopamine in 9449 (16 %), and phenylephrine in 7508 (13 %) ICU days. The VUInorepinephrine increased from 0.24 in 2007 to 0.46 in 2013 and VUIphenylephrine decreased from 0.20 in 2007 to 0.08 in 2013 (p < 0.001 both). For epinephrine, dopamine, and vasopressin VUI did not change over the course of study.

Conclusion: Vasopressors were used in about one fourth of ICU admissions and about one-fifth of ICU days. Although vasopressin is the most commonly used vasopressor, the use of norepinephrine found to have an increasing trajectory.

Keywords: Dopamine; Epinephrine; Intensive care unit; Norepinephrine; Phenylephrine; Shock; Vasopressin; Vasopressors.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Trend of specific vasopressor use in all ICUs from 2007 to 2013. Note: SSC = Surviving Sepsis Campaign
Fig. 2
Fig. 2
Relative changes in each VUI over the course of study based on ICU type. Note: * = statistically significant
Fig. 3
Fig. 3
a Trend of specific vasopressor use in Cardiac Surgery ICU from 2007 to 2013. b Trend of specific vasopressor use in Cardiac Care Unit from 2007 to 2013. c Trend of specific vasopressor use in Medical ICU from 2007 to 2013. d Trend of specific vasopressor use in Surgical ICU from 2007 to 2013. e Trend of specific vasopressor use in Mixed ICU from 2007 to 2013
Fig. 4
Fig. 4
Trend of the use of low-dose dopamine (<3 mcg/kg/min) in ICU subgroups

References

    1. Bonanno FG. Clinical pathology of the shock syndromes. J Emerg Trauma Shock. 2011;4(2):233–243. doi: 10.4103/0974-2700.82211. - DOI - PMC - PubMed
    1. Bonanno FG. Shock - A reappraisal: The holistic approach. J Emerg Trauma Shock. 2012;5(2):167–177. doi: 10.4103/0974-2700.96487. - DOI - PMC - PubMed
    1. Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5(1):4–11. doi: 10.4161/viru.27372. - DOI - PMC - PubMed
    1. Nasa P, Juneja D, Singh O. Severe sepsis and septic shock in the elderly: An overview. World J Crit Care Med. 2012;1(1):23–30. doi: 10.5492/wjccm.v1.i1.23. - DOI - PMC - PubMed
    1. Bone RC. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome) JAMA. 1992;268(24):3452–3455. doi: 10.1001/jama.1992.03490240060037. - DOI - PubMed

Substances

LinkOut - more resources